COMMUNIQUÉS West-GlobeNewswire

Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
15/12/2025
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of [...]
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
15/12/2025
A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive’s proprietary TCR-antigen datasets for research and development in [...]
Earth Science Tech, Inc. Receives FINRA Clearance on Form 211 to Initiate Quotations
15/12/2025
MIAMI, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today [...]
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission
15/12/2025
New PDUFA Target Action Date of January 14, 2026 set by FDA MIAMI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“ [...]
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor Functional Beverage Distribution with Three New Direct Store Delivery Partners Across Maine and Pennsylvania
15/12/2025
WESTBROOK, Maine, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced new Direct Store Delivery (DSD) [...]
Dentsply Sirona Declares Quarterly Cash Dividend
15/12/2025
CHARLOTTE, N.C., Dec. 15, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of [...]
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
15/12/2025
HOUSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the [...]
Vor Bio Announces $150 Million Private Placement
15/12/2025
BOSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it has entered into a securities purchase [...]
Seismic Therapeutic to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026
15/12/2025
WATERTOWN, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Seismic Therapeutic, Inc. , the machine learning immunology company, today announced that Jo Viney, Ph.D., Founder, President and Chief Executive Officer, will present [...]
NeuroSigma Completes $1 Million Investment into High-Volume Manufacturing Line for Second Generation Monarch eTNS® Device
15/12/2025
Armstrong Asia of Singapore selected as NeuroSigma’s manufacturing partner Investment led by Checkmate Capital as part of strategic partnership with Armstrong Asia First commercial units to be delivered in March 2026 [...]
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
15/12/2025
CARMEL, Ind., Dec. 15, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the [...]
Bicara Therapeutics to Present at the J.P. Morgan 2026 Annual Healthcare Conference on Monday, January 12
15/12/2025
BOSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Big Nova Gives $3 Million to Advance NMDP’s Mission and Help More Patients Receive Blood Stem Cell Transplants
15/12/2025
Family donations over a decade inspired by loved one’s life-saving transplant helped NMDP surpass $100 million campaign goal MINNEAPOLIS and ORLANDO, Fla., Dec. 15, 2025 (GLOBE NEWSWIRE) -- NMDP SM announced today that [...]
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
15/12/2025
CORAL GABLES, Fla., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and [...]
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS
15/12/2025
WEST PALM BEACH, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”), announces Chief Executive Officer Seamus Lagan has provided the following Year-End Review to shareholders: FOXO [...]
NetraMark Achieves Major FDA Milestone
15/12/2025
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical [...]
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
15/12/2025
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Sienna Announces December Dividend
15/12/2025
MARKHAM, Ontario, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
OKYO Pharma Announces Chairman and Founder Acquires Shares
15/12/2025
LONDON and NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an [...]

Pages